Hologic Showcased Latest Advances at Virtual ECR Congress 2020
|
By LabMedica International staff writers Posted on 20 Aug 2020 |
|
Illustration
Hologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.
ECR 2020 was the first ever online congress to be held by the European Society of Radiology (ESR) due to the COVID-19 pandemic and attracted a record 15,265 professional delegates from over 130 countries. The Virtual Exhibition was attended by 216 companies which demonstrated their products, hosted webinars and invited attendees to visit their very own digital booths. Hologic also used its virtual booth at ECR 2020 to demonstrate how the company’s clinically proven, integrated solutions incorporating artificial intelligence (AI) can support management of patients across the breast health continuum of care.
At ECR 2020, Hologic demonstrated its Unifi Workspace solution which integrates reading of MRI, ultrasound and mammography into one dedicated platform, and is designed to allow for more efficient review of breast images. The company also showcased its 3DQuorum Imaging Technology, Powered by Genius AI, which significantly reduces mammography exam reading times without compromising image quality, sensitivity or accuracy.
Also on display at Hologic’s virtual booth at ECR 2020 was the company’s Faxitron Path+ Specimen Radiography System which enables pathologists to image a wide range of specimens of varying sizes and have immediate access to high-definition X-ray images, directly in the pathology lab. Hologic also demonstrated its Faxitron Trident HD Specimen Radiography System which delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.
Among other innovations showcased at ECR 2020 by Hologic was the LOCalizer Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System, a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. Attendees to Hologic’s virtual booth at ECR 2020 also got a glimpse of the company’s new Aixplorer Mach 30 Breast Ultrasound System which provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display.
Related Links:
Hologic, Inc.
ECR 2020 was the first ever online congress to be held by the European Society of Radiology (ESR) due to the COVID-19 pandemic and attracted a record 15,265 professional delegates from over 130 countries. The Virtual Exhibition was attended by 216 companies which demonstrated their products, hosted webinars and invited attendees to visit their very own digital booths. Hologic also used its virtual booth at ECR 2020 to demonstrate how the company’s clinically proven, integrated solutions incorporating artificial intelligence (AI) can support management of patients across the breast health continuum of care.
At ECR 2020, Hologic demonstrated its Unifi Workspace solution which integrates reading of MRI, ultrasound and mammography into one dedicated platform, and is designed to allow for more efficient review of breast images. The company also showcased its 3DQuorum Imaging Technology, Powered by Genius AI, which significantly reduces mammography exam reading times without compromising image quality, sensitivity or accuracy.
Also on display at Hologic’s virtual booth at ECR 2020 was the company’s Faxitron Path+ Specimen Radiography System which enables pathologists to image a wide range of specimens of varying sizes and have immediate access to high-definition X-ray images, directly in the pathology lab. Hologic also demonstrated its Faxitron Trident HD Specimen Radiography System which delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.
Among other innovations showcased at ECR 2020 by Hologic was the LOCalizer Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System, a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. Attendees to Hologic’s virtual booth at ECR 2020 also got a glimpse of the company’s new Aixplorer Mach 30 Breast Ultrasound System which provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display.
Related Links:
Hologic, Inc.
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
All-in-One Molecular System
AIO M160
Latest Business News
Channels
Clinical Chemistry
view channel
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more
Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more
Molecular Diagnostics
view channel
Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer
Accurate identification of aggressive prostate cancer subtypes can be difficult when tumors lose expression of lineage markers used in routine pathology. Small cell carcinoma of the prostate, in particular,... Read more
Rapid Multiplex PCR Test Detects 11 Gastrointestinal Pathogens from Single Sample
Cepheid’s Xpert GI Panel has received CE marking under the In Vitro Diagnostic Medical Devices Regulation (IVDR) and is expected to begin shipping to countries that accept the CE mark in the coming weeks.... Read more
Hematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Immunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read more
Microbiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read more
Pathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read more
Technology
view channel
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. Rapid, on-the-spot testing can shorten turnaround times... Read more
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read more
Industry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more
